My interest in immunology dates back to my PhD in 1994-1998. During this period I became more and more convinced that our immune system is the most powerful tool to chase cancer cells all over the body.
Therefore I started, after finishing my Medical School, a specialisation in Hematology and Medical Oncology.
My Post-Doc focussed subsequently in 2001-2003 on checkpoint inhibition via programmed death receptor-1 (PD-1).
Since then I have dedicated all my research work in developing together with many other researchers cancer immunotherapy further.
After finishing my spezialization and having established my own research group in Regensburg, Germany, I was appointed staff member Medical Oncology and Research Group Leader Tumorimmunology at the Netherlands Cancer Institute, Amsterdam.
My current work comprises treatment of patients with immunotherapy, translational research, lecturing, and advisory roles.